Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

Abstract Background Obesity has increased in recent years with consequences on diabetes and other comorbidities. Thus, 1 out of 3 diabetic patients suffers cardiovascular disease (CVD). The network among glucose, immune system, endothelium and epicardial fat has an important role on pro-inflammatory...

Full description

Bibliographic Details

Published in:	Cardiovascular Diabetology
Main Authors:	David García-Vega, David Sánchez-López, Gemma Rodríguez-Carnero, Rocío Villar-Taibo, Juan E. Viñuela, Adán Lestegás-Soto, Ana Seoane-Blanco, María Moure-González, Susana B. Bravo, Ángel L. Fernández, José R. González-Juanatey, Sonia Eiras
Format:	Article
Language:	English
Published:	BMC 2024-01-01
Subjects:	Semaglutide Epicardial fat Obesity Atherosclerosis
Online Access:	https://doi.org/10.1186/s12933-023-02096-9